Several reports showed that AMPK activation is involved in anti-inflammatory effects in cellular, preclinical, and clinical studies, e.g., on diabetes and obesity [9,22]. This evidence concerns the gene PRKAA1 and obesity due to melanocortin 4 receptor deficiency.